Dulac Edward J III
- SEC CIK
- 0001821530
In the past year, 3 open-market sale filings worth $234.2K and no purchases.
Current role at each company
- NTLA Intellia Therapeutics, Inc.EVP, Chief Financial Officeras of Jul 24, 2026
- FATE Fate Therapeutics IncChief Financial Officeras of Mar 5, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $234.2K
- 3 filings
- Net
- −$234.2K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Dulac Edward J III as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
NTLA Intellia Therapeutics, Inc.
EVP, Chief Financial Officer4 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 24, 2026 (view filing)5:26 PM ET | Jul 22 | 2 days | Dulac Edward J IIIEVP, Chief Financial Officer | SSale | −8.11K | $11.25 | −$91.2K | −5.2%148.2K after | |
| Jul 6, 2026 (view filing)5:01 PM ET | Jul 2 | 4 days | Dulac Edward J IIIEVP, Chief Financial Officer | SSale | −4.68K | $18.00 | −$84.2K | −2.9%156.3K after | 10b5-1 |
| Jan 7, 2026 (view filing) | Jan 5 | 2 days | Dulac Edward J IIIEVP, Chief Financial Officer | SSale | −6.38K | $9.21 | −$58.8K | −6.0%99.7K after | |
| Jul 25, 2025 (view filing) | Jul 23 | 2 days | Dulac Edward J IIIEVP, Chief Financial Officer | SSale | −7.46K | $14.02 | −$104.6K | −6.6%106.1K after |
FATE Fate Therapeutics Inc
Chief Financial Officer13 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 5, 2024 (view filing) | Mar 4 | 1 day | Dulac Edward J IIIChief Financial Officer | SSale | −2.45K | $7.77 | −$19.0K | −2.4%101.5K after | 10b5-1 |
| Jan 30, 2024 (view filing) | Jan 29 | 1 day | Dulac Edward J IIIChief Financial Officer | SSale | −1.85K | $5.00 | −$9.24K | −1.7%103.9K after | 10b5-1 |
| Jan 10, 2024 (view filing) | Jan 9 | 1 day | Dulac Edward J IIIChief Financial Officer | SSale | −7.03K | $4.37 | −$30.7K | −6.2%105.8K after | |
| Jan 3, 2024 (view filing) | Jan 2 | 1 day | Dulac Edward J IIIChief Financial Officer | SSale | −5.18K | $3.66 | −$19.0K | −4.4%112.8K after | 10b5-1 |
| Dec 19, 2023 (view filing) | Dec 18 | 1 day | Dulac Edward J IIIChief Financial Officer | SSale | −1.58K | $3.50 | −$5.55K | −1.3%118.0K after | 10b5-1 |
| Aug 21, 2023 (view filing) | Aug 18 | 3 days | Dulac Edward J IIIChief Financial Officer | SSale | −4.72K | $2.80 | −$13.2K | −3.8%119.6K after | |
| Jul 6, 2023 (view filing) | Jul 5 | 1 day | Dulac Edward J IIIChief Financial Officer | SSale | −5.18K | $4.83 | −$25.0K | −4.0%124.3K after | 10b5-1 |
| Jan 11, 2023 (view filing) | Jan 10 | 1 day | Dulac Edward J IIIChief Financial Officer | SSale | −7.33K | $5.24 | −$38.4K | −5.4%129.5K after | |
| Aug 19, 2022 (view filing) | Aug 18 | 1 day | Dulac Edward J IIIChief Financial Officer | SSale | −5.13K | $29.81 | −$153.1K | −3.6%136.8K after | 2 lots |
| Jan 13, 2022 (view filing) | Jan 11 | 2 days | Dulac Edward J IIIChief Financial Officer | SSale | −1.77K | $48.45 | −$85.8K | −1.6%108.6K after | 2 lots |